Jazz Pharmaceuticals launches USD 1 billion exchangeable senior notes offering due 2032

PUBT · 3d ago
Jazz Pharmaceuticals launches USD 1 billion exchangeable senior notes offering due 2032
  • Jazz Pharmaceuticals launched a private offering of USD 1 billion exchangeable senior notes due 2032.
  • Deal includes a 13-day option for initial purchasers to buy up to an additional USD 150 million of notes.
  • Net proceeds earmarked for general corporate purposes.
  • Plans concurrent repurchase of up to USD 225 million ordinary shares from note buyers, funded with existing cash.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608260700PR_NEWS_USPR_____SF33838) on August 26, 2026, and is solely responsible for the information contained therein.